ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the closing of its upsized underwritten public offering of 1,275,000 units, with each
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 80 points on Monday.
The Dow traded down 0.21% to 33,853.11 while the NASDAQ fell 0.60% to 11,934.76. The S&P 500 also fell, dropping, 0.46% to 4,117.44.